SEARCH

SEARCH BY CITATION

References

  • 1
    Chalifour LE, Fahmy R, Holder EL, Hutchinson EW, Osterland CK, Schipper HM, Wang E 1994 A method for analysis of gene expression patterns. Anal Biochem 216:299304.
  • 2
    Zhao N, Hashida H, Takahashi N, Misumi Y, Sakaki Y 1995 High-density cDNA filter analysis: A novel approach for large-scale quantitative analysis of gene expression. Gene 166:207213.
  • 3
    DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM 1996 Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nat Genet 14:457460.
  • 4
    Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmor J, Wooley DE, Davis RW 1997 Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94:21502155.
  • 5
    Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL 1996 Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:16751680.
  • 6
    Piétu G, Alibert O, Guichard V, Lamy B, Bois F, Leroy E, Mariage-Samson R, Houlgatte R, Soularue P, Auffray C 1996 Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array. Genome Res 6:492503.
  • 7
    Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW 1996 Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93:1061410619.
  • 8
    Apert ME 1906 De l'acrocéphalosyndactilie. Bull Soc Med Hôp Paris 23:13101313.
  • 9
    Wilkie AOM, Slane SF, Oldridge M, Poole MD, Asworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P 1995 Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9:165172.
  • 10
    Lomri A, Lemonnier J, Hott M, de Parseval N, Lajeunie E, Munnich A, Renier D, Marie PJ 1998 Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest 101:13101317.
  • 11
    Lemonnier J, Hott M, Delannoy P, Lomri A, Modrowski D, Marie PJ 2000 Down regulation of fibroblast growth factor receptor-2 in Apert syndromic craniosynostosis. Exp Cell Res 256:158167.
  • 12
    Fragale A, Tartaglia M, Bernardini S, Di Stasi AM, Di Rocco C, Velardi F, Teti A, Battaglia PA, Migliaccio S 1999 Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Pathol 154:14651477.
  • 13
    De Pollak C, Renier D, Hott M, Marie PJ 1996 Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis) J Bone Miner Res 11:401407.
  • 14
    Lemonnier J, Hay E, Delannoy P, Lomri A, Caverzasio J, Marie PJ 2000 Role of N-cadherin and protein kinase C alpha in osteoblast gene over-expression induced by the Ser252 Trp fibroblast growth factor receptor-2 mutation in Apert craniosynostosis. Calcif Tissue Int 66(Suppl):102S.
  • 15
    Chedid M, Shirakawa F, Naylor P, Mizel SB 1989 Signal transduction pathway for IL-1. Involvement of a pertussis toxin-sensitive GTP-binding protein in the activation of adenylate cyclase. J Immunol 142:43014306.
  • 16
    Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, Bokoch GM 1995 Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 270:2393423936.
  • 17
    Beresford JN, Gallagher JA, Gowen M, Couch M, Poser J, Wood DD, Russell RGG 1984 The effects of monocyte-conditioned medium and interleukin 1 on the synthesis of collagenous and non-collagenous proteins by mouse bone and human bone cells in vitro. Biochim Biophys Acta 801:5865.
  • 18
    Canalis E 1986 Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology 118:7481.
  • 19
    Ohmori Y, Hanazawa S, Amano S, Hirose K, Kumegawa M, Kitano S 1988 Effects of recombinant human interleukin 1 alpha and interleukin 1 beta on cell growth and alkaline phosphatase of the mouse osteoblastic cell line MC3T3/E0. Biochim Biophys Acta 43:162166.
  • 20
    Evans DB, Bunning RA, Russell RG 1990 The effects of recombinant human interleukin-1 beta on cellular proliferation and the production of prostaglandin E1, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. Biochem Biophys Res Commun 166:208216.
  • 21
    Dinarello CA 1996 Biologic basis for interleukin-1 in disease. Blood 87:20952147.
  • 22
    Tsuboi M, Kawakami A, Nakashima T, Matsuoka N, Urayama S, Kawabe Y, Fujiyama K, Kiriyama T, Aoyagi TM, Maeda K, Eguchi K 1999 Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. Lab Clin Med 134:222231.
  • 23
    Rice DP, Kim HJ, Thesleff I 1999 Apoptosis in murine calvarial bone and suture development. Eur J Oral Sci 107:265275.
  • 24
    Hall A 1998 Rho GTPases and the actin cytoskeleton. Science. 279:509514.
  • 25
    Hall A 1998 G proteins and small GTPases: Distant relatives keep in touch. Science. 280:20742075.
  • 26
    Aspenstrom P 1999 Effectors for the Rho GTPases. Curr Opin Cell Biol 11:95102.
  • 27
    Esteve P, del Peso L, Lacal JC 1995 Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis. Oncogene 11:26572665.
  • 28
    Montaner S, Perona R, Saniger L, Lacal JC 1998 Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases. J Biol Chem 273:1277912785.
  • 29
    Teramoto H, Crespo P, Coso OA, Igishi T, Xu N, Gutkind JS 1996 The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells. Evidence for a Pak-independent signaling pathway. J Biol Chem 271:2573125734.